This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Howard Amital: Innovator in Autoimmune Disease Treatment
Introduction
Howard Amital is a notable inventor based in Gedera, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative work has led to the development of synthetic peptides that hold promise for therapeutic applications.
Latest Patents
Amital holds 1 patent for his invention titled "Synthetic peptides for the treatment of autoimmune diseases." This patent describes synthetic peptides that include a plurality of epitopes, each derived from different proteins, as well as peptides containing multiple citrullinated residues. The invention emphasizes the use of these peptides in treating autoimmune diseases and disorders.
Career Highlights
Amital is associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where he continues to advance his research and innovations. His work is pivotal in the ongoing quest to find effective treatments for complex autoimmune conditions.
Collaborations
Throughout his career, Amital has collaborated with esteemed colleagues such as Yehuda Shoenfeld and Smadar Gertel. These partnerships have enriched his research and contributed to the development of groundbreaking medical solutions.
Conclusion
Howard Amital's contributions to the field of autoimmune disease treatment through his innovative synthetic peptides represent a significant advancement in medical research. His work continues to inspire and pave the way for future innovations in healthcare.